With 'Charlie,' Pfizer is building a new generative AI platform for pharma marketing

With 'Charlie,' Pfizer is building a new generative AI platform for pharma marketing

Pfizer has developed its own generative AI platform called “Charlie,” named after Pfizer co-founder Charles Pfizer.

Additional coverage:

• Sources claim Roku is hinting at the pending sunsetting of its OneView platform.
• Midway through Q1, publishers share early signs of digital ad growth. More in this week's Digiday+ Media Briefing.
• Walmart's acquisition of smart TV maker Vizio will bolster retail media offering Walmart Connect, adding streaming capabilities that will help it attract more brand marketing ad dollars.
• Video advertising company Pixability has partnered with Black-owned digital video network Culture Genesis to expand its diversity efforts.
• In this week’s Digiday+ Research Briefing, we examine how Snapchat is pitching itself as an alternative to current social platforms, how Priceline and other e-commerce companies are approaching generative AI, and how legacy programmatic media buying practices often disadvantage Black-owned media companies.